Brief: Dermapharm Holding: Revenue To Exceed One Billion In 2023

Dermapharm Holding SE

14/03/2023 06:34

March 14 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * REVENUE EXCEEDS ONE BILLION FOR THE FIRST TIME
    * REVENUE EXPECTED TO CONTINUE GROWING IN 2023
    * FY ADJUSTED CONSOLIDATED EBITDA MARGIN: 35.1%
    * FY CONSOLIDATED REVENUE UP 8.7 % YEAR ON YEAR TO EUR 1,025
MILLION
    * BOARD OF MANAGEMENT EXPECTS CONSOLIDATED REVENUE TO AMOUNT
TO
BETWEEN EUR 1,080 AND 1,110 MILLION IN FINANCIAL YEAR 2023
    * OUTLOOK 2023: ADJUSTED CONSOLIDATED EBITDA IS FORECAST AT
BETWEEN EUR 300 AND 310 MILLION

Source text for Eikon:  ID:nEQ9G2vgPa 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))